E-4031: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 1: Line 1:
'''E-4031''' is a class III [[antiarrhythmic agent]] that is often used in scientific research to understand the properties and effects of [[hERG]] potassium channels. It is not used in medical practice due to its potential for inducing [[torsades de pointes]], a specific type of abnormal heart rhythm that can lead to [[sudden cardiac death]].
== E-4031 ==
 
[[File:E-4031.png|thumb|right|Chemical structure of E-4031]]
 
'''E-4031''' is a chemical compound known for its role as a selective blocker of the [[hERG]] (human Ether-à-go-go-Related Gene) [[potassium channel]]. This compound is of significant interest in the field of [[cardiology]] and [[pharmacology]] due to its effects on cardiac repolarization and its potential to induce [[arrhythmias]].


== Mechanism of Action ==
== Mechanism of Action ==
E-4031 works by blocking hERG potassium channels, which are responsible for the repolarization phase of the cardiac action potential. By blocking these channels, E-4031 prolongs the duration of the action potential, thereby prolonging the [[QT interval]] on the [[electrocardiogram]] (ECG). This can lead to a type of ventricular tachycardia called torsades de pointes, which can degenerate into ventricular fibrillation and cause sudden cardiac death.


== Use in Research ==
E-4031 functions by inhibiting the hERG potassium channels, which are crucial for the repolarization phase of the cardiac [[action potential]]. These channels are responsible for the rapid delayed rectifier potassium current (I<sub>Kr</sub>), which helps in the repolarization of the cardiac [[myocyte]]s. By blocking these channels, E-4031 prolongs the [[QT interval]] on the [[electrocardiogram]] (ECG), which can lead to [[Torsades de Pointes]], a type of polymorphic ventricular tachycardia.
Despite its potential for inducing life-threatening arrhythmias, E-4031 is widely used in research due to its ability to selectively block hERG potassium channels. This makes it a valuable tool for studying the role of these channels in cardiac electrophysiology and for testing the potential cardiotoxicity of new drugs.
 
== Clinical Significance ==
 
The ability of E-4031 to block hERG channels makes it a valuable tool in [[drug development]] and [[safety pharmacology]]. Many drugs are screened for hERG channel activity to predict their potential to cause QT interval prolongation and associated cardiac risks. E-4031 is often used as a reference compound in these studies.
 
== Research Applications ==
 
In [[research]], E-4031 is used to study the electrophysiological properties of cardiac cells and to understand the mechanisms underlying drug-induced [[cardiotoxicity]]. It is also employed in the development of new therapeutic agents that require careful assessment of their effects on cardiac repolarization.
 
== Safety and Toxicity ==


== Side Effects ==
While E-4031 is a powerful research tool, it is not used therapeutically due to its potential to cause serious cardiac arrhythmias. Its use is primarily restricted to controlled laboratory settings where its effects can be closely monitored.
The main side effect of E-4031 is the induction of torsades de pointes, a potentially fatal arrhythmia. Other side effects can include [[dizziness]], [[nausea]], and [[vomiting]], although these are less common.


== See Also ==
== Related Pages ==
* [[Antiarrhythmic agent]]
* [[hERG]]
* [[Torsades de pointes]]
* [[Sudden cardiac death]]


[[Category:Antiarrhythmic agents]]
* [[hERG channel]]
[[Category:Potassium channel blockers]]
* [[QT interval]]
[[Category:Cardiac electrophysiology]]
* [[Torsades de Pointes]]
* [[Cardiac action potential]]
* [[Pharmacology]]


{{medicine-stub}}
[[Category:Pharmacology]]
[[Category:Cardiology]]

Latest revision as of 03:28, 13 February 2025

E-4031[edit]

Chemical structure of E-4031

E-4031 is a chemical compound known for its role as a selective blocker of the hERG (human Ether-à-go-go-Related Gene) potassium channel. This compound is of significant interest in the field of cardiology and pharmacology due to its effects on cardiac repolarization and its potential to induce arrhythmias.

Mechanism of Action[edit]

E-4031 functions by inhibiting the hERG potassium channels, which are crucial for the repolarization phase of the cardiac action potential. These channels are responsible for the rapid delayed rectifier potassium current (IKr), which helps in the repolarization of the cardiac myocytes. By blocking these channels, E-4031 prolongs the QT interval on the electrocardiogram (ECG), which can lead to Torsades de Pointes, a type of polymorphic ventricular tachycardia.

Clinical Significance[edit]

The ability of E-4031 to block hERG channels makes it a valuable tool in drug development and safety pharmacology. Many drugs are screened for hERG channel activity to predict their potential to cause QT interval prolongation and associated cardiac risks. E-4031 is often used as a reference compound in these studies.

Research Applications[edit]

In research, E-4031 is used to study the electrophysiological properties of cardiac cells and to understand the mechanisms underlying drug-induced cardiotoxicity. It is also employed in the development of new therapeutic agents that require careful assessment of their effects on cardiac repolarization.

Safety and Toxicity[edit]

While E-4031 is a powerful research tool, it is not used therapeutically due to its potential to cause serious cardiac arrhythmias. Its use is primarily restricted to controlled laboratory settings where its effects can be closely monitored.

Related Pages[edit]